RM Global Partners raises $30m

View the latest capital raises

RM Global Partners raises $30 Million to date for its New Israel-Based Biopharma Fund.

The Fund is dedicated to the portfolio of FutuRx, Israel’s leading early-stage biopharma incubator. There are currently 10 portfolio companies in FutuRx, developing breakthrough technologies, with up to 30 additional portfolio companies to be formed.